As of 2018, cryptococcal antigen (CrAg) screening in patients with advanced human immunodeficiency virus (HIV) disease (AHD) was not routinely implemented in Nigeria despite being recommended in the national HIV treatment guidelines. The gene discussed is AGAP3; the disease is mitochondrial DNA depletion syndrome 4a.